Search Results

Filter
  • 1-10 of  192,519 results for ""ATHEROSCLEROSIS""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Tiaogan daozhuo formula attenuates atherosclerosis via activating AMPK -PPARγ-LXRα pathway.

  • Authors : Zhang Y; School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China. Electronic address: .; Zeng M

Subjects: PPAR gamma*/PPAR gamma*/PPAR gamma*/metabolism ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/drug therapy ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/prevention & control

  • Source: Journal of ethnopharmacology [J Ethnopharmacol] 2024 Apr 24; Vol. 324, pp. 117814. Date of Electronic Publication: 2024 Jan 28.Publisher: Elsevier Sequoia Country of Publication: Ireland NLM ID: 7903310 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

CD38 deficient mice are not protected from atherosclerosis.

  • Authors : Kong XY; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway. Electronic address: .; Lauritzen KH

Subjects: Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/genetics ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/prevention & control ; Proprotein Convertase 9*

  • Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2024 Apr 23; Vol. 705, pp. 149734. Date of Electronic Publication: 2024 Feb 27.Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Disulfiram Reduces Atherosclerosis and Enhances Efferocytosis, Autophagy, and Atheroprotective Gut Microbiota in Hyperlipidemic Mice.

  • Authors : Traughber CA; Center for Gene Regulation in Health and Disease Cleveland State University Cleveland OH USA.; Department of Biology, Geology, and Environmental Sciences Cleveland State University Cleveland OH USA.

Subjects: Gastrointestinal Microbiome* ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/drug therapy ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/genetics

  • Source: Journal of the American Heart Association [J Am Heart Assoc] 2024 Apr 16; Vol. 13 (8), pp. e033881. Date of Electronic Publication: 2024 Apr 02.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Colchicine in atherosclerotic cardiovascular disease.

  • Authors : Tucker B; Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia.

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/drug therapy ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/prevention & control ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/drug therapy

  • Source: Heart (British Cardiac Society) [Heart] 2024 Apr 15; Vol. 110 (9), pp. 618-625. Date of Electronic Publication: 2024 Apr 15.Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 9602087 Publication Model: Electronic Cited Medium: Internet ISSN: 1468-201X

Record details

×
Academic Journal

Rewiring Endothelial Sphingolipid Metabolism to Favor S1P Over Ceramide Protects From Coronary Atherosclerosis.

  • Authors : Manzo OL; Department of Pathology and Laboratory Medicine, Cardiovascular Research Institute, Brain and Mind Research Institute (O.L.M., J.N., L.S., A.M., L.R., S.P., A.B., A.D.L.).; Nour J

Subjects: Coronary Artery Disease*/Coronary Artery Disease*/Coronary Artery Disease*/genetics ; Coronary Artery Disease*/Coronary Artery Disease*/Coronary Artery Disease*/prevention & control ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/genetics

  • Source: Circulation research [Circ Res] 2024 Apr 12; Vol. 134 (8), pp. 990-1005. Date of Electronic Publication: 2024 Mar 08.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0047103 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

CNP Ameliorates Macrophage Inflammatory Response and Atherosclerosis.

  • Authors : Bao Q; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, China (Q.B., B.Z., L.Z., Q.Y., X.M., X.L., S.Z., M.Y., Y.Z., J.C., T.L., G.L.).; Zhang B

Subjects: Plaque, Atherosclerotic*/Plaque, Atherosclerotic*/Plaque, Atherosclerotic*/metabolism ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/drug therapy ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/genetics

  • Source: Circulation research [Circ Res] 2024 Apr 12; Vol. 134 (8), pp. e72-e91. Date of Electronic Publication: 2024 Mar 08.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0047103 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Macrophage-mannose-receptor-targeted photoactivatable agent for in vivo imaging and treatment of atherosclerosis.

  • Authors : Lee SY; Multimodal Imaging and Theranostic Laboratory, Cardiovascular Center, Korea University Guro Hospital, Seoul 08308, Republic of Korea; Division of Cardiology, Department of Internal Medicine, CHA Bundang Medical Center, Seongnam 13496, Republic of Korea.

Subjects: Photochemotherapy*/Photochemotherapy*/Photochemotherapy*/methods ; Nanoparticles*/Nanoparticles*/Nanoparticles*/chemistry ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/diagnostic imaging

  • Source: International journal of pharmaceutics [Int J Pharm] 2024 Apr 10; Vol. 654, pp. 123951. Date of Electronic Publication: 2024 Feb 27.Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Single-Cell Multimodal Profiling of Atherosclerosis Identifies CD200 as a Cell Surface Lineage Marker of Vascular Smooth Muscle Cells and Their Derived Cells.

  • Authors : Bashore AC; Division of Cardiology, Department of Medicine, Vagelos College of Physicians and Surgeons (A.C.B., A.C., C.I., C.X., R.C.B., M.P.R.), Columbia University, New York, NY.; Chung A

Subjects: Muscle, Smooth, Vascular*/Muscle, Smooth, Vascular*/Muscle, Smooth, Vascular*/metabolism ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/genetics ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/metabolism

  • Source: Circulation [Circulation] 2024 Apr 09; Vol. 149 (15), pp. 1231-1233. Date of Electronic Publication: 2024 Apr 08.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

The IRG1-itaconate axis protects from cholesterol-induced inflammation and atherosclerosis.

  • Authors : Cyr Y; Cardiovascular Research Center, New York University Grossman School of Medicine, New York, NY 10016.; Bozal FK

Subjects: Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/drug therapy ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/genetics ; Plaque, Atherosclerotic*/Plaque, Atherosclerotic*/Plaque, Atherosclerotic*/drug therapy

  • Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Apr 09; Vol. 121 (15), pp. e2400675121. Date of Electronic Publication: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

HEG1 Protects Against Atherosclerosis by Regulating Stable Flow-Induced KLF2/4 Expression in Endothelial Cells.

  • Authors : Tamargo IA; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA (I.A.T., K.I.B., C.X., D.W.K., Y.K., A.A., D.W., C.D., N.V.-R., S.K., C.P., R.C., J.J., S.C., P.K., S.T., K.J., H.J.).; Molecular and Systems Pharmacology Program (I.A.T., D.W., H.J.), Emory University, Atlanta, GA.

Subjects: Plaque, Atherosclerotic*/Plaque, Atherosclerotic*/Plaque, Atherosclerotic*/metabolism ; Hypercholesterolemia*/Hypercholesterolemia*/Hypercholesterolemia*/genetics ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/genetics

  • Source: Circulation [Circulation] 2024 Apr 09; Vol. 149 (15), pp. 1183-1201. Date of Electronic Publication: 2023 Dec 15.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  192,519 results for ""ATHEROSCLEROSIS""